Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -17.40x is 52% below its 2-year average of -11.48x, around the middle of its 2-year range (-52.24x–7.79x).
20.98% above its 12-month average of -22.02x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -11.23x.
INTEREST COVERAGE RATIO
-17.40x
INTEREST COVERAGE RATIO AVG TTM
-22.02x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+20.98%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-172.94%
vs the sector median at left
NewGenIvf Group Limited
Market Cap
$6235.00
Interest Coverage Ratio
-17.40x
TTM Avg
-22.02x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30054.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$71053.00
Interest Coverage Ratio
-498.70x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$95475.00
Interest Coverage Ratio
-655.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106970.00
Interest Coverage Ratio
894.77x
TTM Avg
894.77x
3Y Avg
894.77x
5Y Avg
894.77x
Market Cap
$252756.00
Interest Coverage Ratio
-795.36x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$378849.00
Interest Coverage Ratio
-103.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6235.00 | -17.40x | -22.02x | N/A | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30054.00 | N/A | N/A | N/A | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30389.00 | N/A | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61172.00 | -5.39x | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $71053.00 | -498.70x | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | -655.06x | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $106970.00 | 894.77x | 894.77x | 894.77x | 894.77x |
| SciSparc Ltd. (SPRC)vs › | $252756.00 | -795.36x | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | -103.60x | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $385197.00 | -18.99x | N/A | N/A | N/A |
Interest Coverage
-17.4x
Debt/Equity
0.18
Current Ratio
3.12
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -11.23x |
| 2025-09-30 | -52.24x |
| 2024-12-31 | -2.59x |
| 2024-09-30 | 0.87x |
| 2023-12-31 | 7.79x |
